Dolby Laboratories, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Dolby Laboratories, Inc. (DLB) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $105.19 million as of 2024-06-28, per its 10-Q filed 2024-08-07.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2024-11-19
- 2024-06-28: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $105.19M.
- 2024-03-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $116.87M.
- 2023-12-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $56.47M.
- 2023-09-29: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $136.66M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months |
|---|---|
| 2024-06-28 | $105.19M 10-Q · filed 2024-08-07 |
| 2024-03-29 | $116.87M 10-Q · filed 2024-05-02 |
| 2023-12-29 | $56.47M 10-Q · filed 2024-02-02 |
| 2023-09-29 | $136.66M 10-K · filed 2024-11-19 |
| 2023-06-30 | $128.42M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $94.30M 10-Q · filed 2023-05-05 |
| 2022-12-30 | $130.06M 10-Q · filed 2023-02-02 |
| 2022-09-30 | $240.17M 10-K · filed 2023-11-17 |
| 2022-07-01 | $236.36M 10-Q · filed 2022-08-09 |
| 2022-04-01 | $257.68M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $132.74M 10-Q · filed 2022-02-04 |
| 2021-09-24 | $40.98M 10-K · filed 2022-11-18 |
| 2020-09-25 | $9.58M 10-K · filed 2021-11-17 |